Deutsche Bank AG trimmed its position in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 17.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 409,543 shares of the company's stock after selling 85,568 shares during the quarter. Deutsche Bank AG owned approximately 0.53% of Owens & Minor worth $3,698,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Sterling Capital Management LLC lifted its holdings in shares of Owens & Minor by 758.3% in the fourth quarter. Sterling Capital Management LLC now owns 2,060 shares of the company's stock worth $27,000 after buying an additional 1,820 shares in the last quarter. Versant Capital Management Inc lifted its holdings in shares of Owens & Minor by 537.6% in the first quarter. Versant Capital Management Inc now owns 3,201 shares of the company's stock worth $29,000 after buying an additional 2,699 shares in the last quarter. Parallel Advisors LLC lifted its holdings in shares of Owens & Minor by 1,387.0% in the first quarter. Parallel Advisors LLC now owns 3,316 shares of the company's stock worth $30,000 after buying an additional 3,093 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Owens & Minor by 713.4% in the first quarter. GAMMA Investing LLC now owns 9,265 shares of the company's stock worth $84,000 after buying an additional 8,126 shares in the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in shares of Owens & Minor in the first quarter worth about $96,000. 98.04% of the stock is owned by hedge funds and other institutional investors.
Owens & Minor Price Performance
NYSE:OMI traded down $0.0250 during mid-day trading on Friday, reaching $5.0550. The stock had a trading volume of 1,825,574 shares, compared to its average volume of 1,902,901. The firm has a 50 day moving average price of $7.36 and a two-hundred day moving average price of $7.64. The stock has a market capitalization of $390.45 million, a P/E ratio of -0.32 and a beta of 1.04. Owens & Minor, Inc. has a one year low of $4.56 and a one year high of $16.63. The company has a debt-to-equity ratio of 3.32, a quick ratio of 0.83 and a current ratio of 0.86.
Owens & Minor (NYSE:OMI - Get Free Report) last released its earnings results on Monday, August 11th. The company reported $0.26 earnings per share for the quarter, missing analysts' consensus estimates of $0.27 by ($0.01). The firm had revenue of $681.90 million during the quarter, compared to the consensus estimate of $2.73 billion. Owens & Minor had a positive return on equity of 26.59% and a negative net margin of 13.78%.The business's quarterly revenue was up 3.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.36 EPS. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS. As a group, analysts expect that Owens & Minor, Inc. will post 1.51 earnings per share for the current year.
Insiders Place Their Bets
In other news, major shareholder Coliseum Capital Management, L bought 492,852 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The stock was bought at an average price of $5.31 per share, for a total transaction of $2,617,044.12. Following the transaction, the insider directly owned 13,100,807 shares of the company's stock, valued at $69,565,285.17. This represents a 3.91% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In the last ninety days, insiders purchased 1,537,852 shares of company stock valued at $8,099,544. Insiders own 3.69% of the company's stock.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on OMI. Baird R W raised shares of Owens & Minor from a "hold" rating to a "strong-buy" rating in a report on Friday, August 8th. Robert W. Baird cut their price objective on Owens & Minor from $10.00 to $7.00 and set an "outperform" rating for the company in a report on Tuesday, August 12th. UBS Group set a $7.00 price objective on Owens & Minor in a report on Wednesday, August 13th. JPMorgan Chase & Co. set a $10.00 price objective on Owens & Minor in a report on Monday, August 11th. Finally, Bank of America cut their price objective on Owens & Minor from $7.50 to $4.75 and set an "underperform" rating for the company in a report on Tuesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $8.29.
Read Our Latest Stock Analysis on Owens & Minor
Owens & Minor Company Profile
(
Free Report)
Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.
Read More

Before you consider Owens & Minor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.
While Owens & Minor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.